Shawn Cross appointed as chief financial officer for Pacira Biosciences

Natalia Elliot | October 25, 2024 | Appointment | Research and Development Pacira Biosciences 

Pacira Biosciences, spcecialist in non-opioid pain therapies, has appointed Shawn Cross as their chief financial officer. In this role, Mr Cross will take over all responsibility for the company’s financial operations.

“I am proud to join Pacira as I am strongly aligned with the company’s important mission to deliver innovative, non-opioid pain therapies. Pacira is on strong financial footing with a business that is generating significant cash flow driven by three best-in-class, market-leading products. I am excited to work with the Pacira leadership team as we invest in our next phase of growth and beyond,” commented Mr Cross.

His expertise stems from 25 years of experience in the biotech industry, in addition to experience gleaned from investment banking and time served on various boards. He still serves on the board of directors for Cyclo Therapuetics, where he was previously appointed as the chief executive officer after leading the company through a merger with Applied Molecular Transport (AMT). Previously, Mr Cross was managing director for Healthcare Investment Banking at JMP Securities Inc, which followed on from his roles in senior positions at Deutsche Bank Securities and Wells Fargo Securities.

Advertisement

Mr Cross holds a Bachelor of Sciences degree in Kinesiology from the University of California, and an MBA from Colombia Business School, both in the US.

Natalia Elliot

25/10/24

Related Content

No items found
The Gateway to Local Adoption Series

Latest content